Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: A preliminary report

Psychiatry and Clinical Neurosciences

Volumn 56, Issue 5, 2002, Pages 499-507

  Hagino, Hirofumi ^a   Suzuki, Michio ^a   Mori, Koichi ^a   Nohara, Shigeru ^a   Yamashita, Ikiko ^a   Takahashi, Tsutomu ^a   Kurokawa, Kenzo ^a   Matsui, Mie ^a   Watanabe, Naoto ^a   Seto, Hikaru ^a   Kurachi, Masayoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Inferior frontal gyrus; N acetylaspartate; Proton magnetic resonance spectroscopy; Schizophrenia; Thalamus; Verbal learning task

Indexed keywords

CHOLINE DERIVATIVE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRONTAL CORTEX; HUMAN; LEARNING; MALE; ONSET AGE; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC ASSESSMENT; RECALL; SCHIZOPHRENIA; STIMULUS RESPONSE; TASK PERFORMANCE; THALAMUS; VERBAL MEMORY; VERBALIZATION;

ADOLESCENT; ADULT; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THALAMUS; VERBAL LEARNING;

EID: 0036791778     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2002.01045.x     Document Type: Article

References (48)

1. Goldberg TE, Weinberger DR, Pliskin NH, Berman KF, Podd MH. Recall memory deficits in schizophrenia: A possible manifestation of prefrontal dysfunction. Schizophr. Res. 1989; 2: 251-257.
2. Saykin AJ, Shtasel DL, Gur RE etal. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 1994; 51: 124-131.
3. Gold JM, Randolph C, Carpenter CJ, Goldberg TE, Weinberger DR. Forms of memory failure in schizophrenia. J. Abnorm. Psychol 1992; 101: 487-494.
4. Kareken DA, Moberg PJ, Gur RC. Proactive inhibition and semantic organization relationship with verbal memory in patients with schizophrenia. J. Int. Neuropsychol. Soc. 1996; 2: 486-493.
5. Koh SD, Kayton L, Berry R. Mnemonic organization in young nonpsychotic schizophrenics. J. Abnorm. Psychol 1973; 81: 299-310.
6. Koh SD. Remembering of verbal materials by schizophrenic young adults. In: Schwartz S (ed.). Language and Cognition in Schizophrenia. Lawrence Erlbaum, Hillsdale, 1978; 59-99.
7. Paulsen JS, Heaton RK, Sadek JR et al. The nature of learning and memory impairments in schziophrenia. J. Int. Neuropsychol. Soc. 1995; 1: 88-89.
8. Demb JB, Desmond JE, Wagner AD, Vaidya CJ, Glover GH, Gabrieli JDE. Semantic encoding and retrieval in the left inferior prefrontal cortex: A functional MRI study of task difficulty and process specificity. J. Neurosci. 1995; 15: 5870-5878.
9. Fletcher PC, Shallice T, Dolan RJ. The functional roles of prefrontal cortex in episodic memory I. Encoding. Brain 1998; 121: 1239-1248.
10. Gershberg FB, Shimamura AP. Impaired use of organizational strategies in free recall following frontal lobe damage. Neuropsychologia 1995; 13: 1305-1333.
11. Fletcher PC, Henson RNA. Frontal lobes and human memory: Insights from functional neuroimaging. Brain 2001; 124: 849-881.
12. Grasby PM, Frith CD, Friston KJ, Bench C, Frackowiak RSJ, Dolan RJ. Functional mapping of brain areas implicated in auditory-verbal memory function. Brain 1993; 116: 1-20.
13. 99mTc-ethyl-cysteinate dimer during a verbal learning task. Schizophr. Res. 2000; 42: 209-222.
14. Andreasen NC, Arndt S, Swayze VII et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266: 294-298.
15. Buchsbaum MS, Someya T, Teng CY et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am. J. Psychiatry 1996; 153: 191-199.
16. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia: Relationship to symptoms and clinical subtype. Am. J. Psychiatry 1998; 155: 1711-1717.
17. Andreasen NC, O'Leary D, Cizadlo T et al. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circutry. Proc. Natl Acad. Sci. USA 1996; 93: 9985-9990.
18. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988; 1: 179-186.
19. Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 1990; 13: 272-276.
20. Hazlett EA, Buchsbaum MS, Byne W et al. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am. J. Psychiatry 1999; 156: 1190-1199.
21. Staal WG, Hulshoff Pol HE, Schnack H, van der Schot AC, Kahn. S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am. J. Psychiatry 1998; 155: 1784-1786.
22. Popken GJ, Bunney WE, Potkin SG, Jones EG. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl Acad. Sci. USA 2000; 97: 9276-9280.
23. Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry 2000; 47: 944-953.
24. Kegeles LS, Humaran TJ, Mann JJ. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol. Psychiatry 1998; 44: 382-398.
25. Soares JC, Innis RB. Neurochemical brain imaging investigations of schizophrenia. Biol. Psychiatry 1999; 46: 600-615.
26. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia. Methodological issues and findings: Part II. Biol. Psychiatry 2000; 48: 369-380.
27. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry 1994; 36: 792-800.
28. Bertolino A, Nawroz S, Mattay VS et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 1996; 153: 1554-1563.
29. Bertolino A, Callicott JH, Nawroz S et al. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998; 18: 1-9.
30. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am. J. Psychiatry 1997; 154: 688-690.
31. Deicken RF, Johnson C, Eliaz Y, Schuff N. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am. J. Psychiatry 2000; 157: 644-647.
32. Fukuzako H, Takeuchi K, Hokazono Y et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: Preliminary report. Psychiatry Res. Neuroimaging 1995; 61: 193-200.
33. Omori M, Murata T, Kimura H et al. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res. Neuroimaging 2000; 98: 155-162.
34. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Waternaux C, Cohen BM. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr. Res. 1996; 19: 55-59.
35. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, 1992.
36. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). The University of Iowa, Iowa City, 1984.
37. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). The University of Iowa, Iowa City, 1984.
38. Silverstein AB. Two- and four-subtest short forms of the Wechsler adult intelligence scale, revised. J. Consult. Clin. Psychol. 1982; 50: 415-418.
39. Bousfield AK, Bousfield WA. Measurement of clustering and of sequential constancies in repeated free recall. Psychol. Rep. 1966; 19: 935-942.
40. Buchanan RW, Vladar K, Barta PB, Pearlson GD. Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry 1998; 155: 1049-1055.
41. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 1991; 48: 996-1001.
42. Rajowska G, Selemon LD, Goldma-Rakic PS. Neuronal and glial somal size in the prefrontal cortex. A post-mortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 1998; 55: 215-224.
43. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch. Gen. Psychiatry 1986; 43: 31-35.
44. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 1995; 52: 805-818.
45. Bertolino A, Kumra S, Callicott JH et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 1998; 155: 1376-1383.
46. Cohen BM, Wan W. The thalamus as a site of action of antipsychotic drugs. Am. J. Psychiatry 1996; 153: 104-106.
47. 2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging. Brain Res. 1998; 813: 367-373.
48. Kurachi M, Yasui S, Shibata R et al. Comparative study of dopamine metabolism with local cerebral glucose utilization in rat brain following the administration of haloperidol decanoate. Biol. Psychiatry 1994; 36: 110-117.